Colin Powell's death sparks misleading claims about COVID-19 vaccines | Inquirer News

Colin Powell’s death sparks misleading claims about COVID-19 vaccines

/ 09:12 AM October 20, 2021

(FILES) In this file photo taken on July 18, 2011, former US Secretary of State Colin Powell speaks at the White House in Washington, DC. - Social media posts claim that Colin Powell's death from complications caused by Covid-19 means vaccines against the disease are ineffective. But Powell had a type of cancer that experts say undermines the efficacy of the shots, and data shows his age left him especially vulnerable. "PROOF this Vaccine does NOT EVEN WORK, or-and is NOT EVEN a REAL VACCINE," said a Facebook post sharing an article about the retired four-star general and former secretary of state's death. (Photo by Jim WATSON / AFP)

In this file photo taken on July 18, 2011, former US Secretary of State Colin Powell speaks at the White House in Washington, DC. (Photo by Jim WATSON / AFP)

WASHINGTON — Social media posts claim that Colin Powell’s death from complications caused by COVID-19 means vaccines against the disease are ineffective. But Powell had a type of cancer that experts say undermines the efficacy of the shots, and data shows his age left him especially vulnerable.

“PROOF this Vaccine does NOT EVEN WORK, or-and is NOT EVEN a REAL VACCINE,” said a Facebook post sharing an article about the retired four-star general and former secretary of state’s death.

Article continues after this advertisement

Powell, a trailblazer in the military and US government, died on October 18 at Walter Reed National Military Medical Center.

FEATURED STORIES

His family confirmed that the 84-year-old was fully vaccinated against COVID-19.

In the immediate aftermath, opponents of the shots seized on that disclosure in numerous online posts as evidence that the vaccines do not work.

Article continues after this advertisement

But Powell was especially vulnerable because of myeloma, a blood cancer that affects plasma cells that help produce antibodies against harmful pathogens.

Article continues after this advertisement

In what might have been his last interview, Powell told journalist Bob Woodward that he had multiple myeloma, as well as a second underlying condition, Parkinson’s disease.

Article continues after this advertisement

“If you had to choose a medical condition that would severely impact or diminish your response to vaccines, it would be multiple myeloma,” said Onyema Ogbuagu, an infectious diseases specialist at Yale School of Medicine.

‘An outlier’

Powell’s condition “severely limited his ability to mount a response to the vaccine… he’s an outlier, unfortunately,” Ogbuagu added.

Article continues after this advertisement

Not only do multiple myeloma patients often mount a poor antibody response to COVID-19 vaccination, Icahn School of Medicine at Mount Sinai researchers “discovered that these patients also have a weak response from a different part of the immune system, known as T cells.”

Samir Parekh, a co-author of the Mount Sinai study, said that treatments for myeloma patients can make them even more immunocompromised.

However, study results showed that COVID-19 shots still offer protection, he said. “There’s no question that the vaccines work.”

Data released by the US Centers for Disease Control and Prevention shows that the elderly are more vulnerable to COVID-19, even if they are vaccinated — and Powell’s age put him in that high-risk group.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

The data from August showed that although the vaccinated were six times less likely to become infected and 11 times less likely to die from the disease, fatalities among those aged 80 and over was almost as high as those aged between 50-64 who were unvaccinated.

EDV
TAGS: Colin Powell, myeloma

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.